DK300090D0 - Fremgangsmaade til fremstilling af leadersekvenser - Google Patents

Fremgangsmaade til fremstilling af leadersekvenser

Info

Publication number
DK300090D0
DK300090D0 DK300090A DK300090A DK300090D0 DK 300090 D0 DK300090 D0 DK 300090D0 DK 300090 A DK300090 A DK 300090A DK 300090 A DK300090 A DK 300090A DK 300090 D0 DK300090 D0 DK 300090D0
Authority
DK
Denmark
Prior art keywords
preparing
procedure
leader sequences
leader
sequences
Prior art date
Application number
DK300090A
Other languages
English (en)
Inventor
Lars Christiansen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Priority to DK300090A priority Critical patent/DK300090D0/da
Publication of DK300090D0 publication Critical patent/DK300090D0/da
Priority to NZ241011A priority patent/NZ241011A/en
Priority to PT99848A priority patent/PT99848A/pt
Priority to PCT/DK1991/000396 priority patent/WO1992011378A1/en
Priority to JP4502056A priority patent/JPH06503957A/ja
Priority to EP92901668A priority patent/EP0563175A1/en
Priority to HU9301801A priority patent/HUT68751A/hu
Priority to IL100408A priority patent/IL100408A0/xx
Priority to FI932831A priority patent/FI932831A0/fi
Priority to IE443391A priority patent/IE914433A1/en
Priority to KR1019930701890A priority patent/KR930703450A/ko
Priority to SK62593A priority patent/SK62593A3/sk
Priority to ZA919932A priority patent/ZA919932B/xx
Priority to CS931192A priority patent/CZ119293A3/cs
Priority to CA002098731A priority patent/CA2098731A1/en
Priority to AU91348/91A priority patent/AU660161B2/en
Priority to MX9102684A priority patent/MX9102684A/es
Priority to NO93932235A priority patent/NO932235L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/036—Fusion polypeptide containing a localisation/targetting motif targeting to the medium outside of the cell, e.g. type III secretion
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Consolidation Of Soil By Introduction Of Solidifying Substances Into Soil (AREA)
  • Prevention Of Electric Corrosion (AREA)
  • Bridges Or Land Bridges (AREA)
  • Building Environments (AREA)
  • Working Measures On Existing Buildindgs (AREA)
DK300090A 1990-12-19 1990-12-19 Fremgangsmaade til fremstilling af leadersekvenser DK300090D0 (da)

Priority Applications (18)

Application Number Priority Date Filing Date Title
DK300090A DK300090D0 (da) 1990-12-19 1990-12-19 Fremgangsmaade til fremstilling af leadersekvenser
NZ241011A NZ241011A (en) 1990-12-19 1991-12-17 Leader sequence for secreting heterologous polypeptides in yeast, vectors using it, yeast cells and process for producing heterologous polypeptides
AU91348/91A AU660161B2 (en) 1990-12-19 1991-12-18 A method of constructing synthetic leader sequences
FI932831A FI932831A0 (fi) 1990-12-19 1991-12-18 Ett foerfarande foer framstaellning av en syntetisk ledarsekvens
IE443391A IE914433A1 (en) 1990-12-19 1991-12-18 A method of constructing synthetic leader sequences
JP4502056A JPH06503957A (ja) 1990-12-19 1991-12-18 合成リーダー配列の構成方法
EP92901668A EP0563175A1 (en) 1990-12-19 1991-12-18 A method of constructing synthetic leader sequences
HU9301801A HUT68751A (en) 1990-12-19 1991-12-18 A method of constructing synthetic leader sequences
IL100408A IL100408A0 (en) 1990-12-19 1991-12-18 Construction of synthetic leader peptide sequences
PT99848A PT99848A (pt) 1990-12-19 1991-12-18 Processo para a preparacao de sequencias lider sinteticas
PCT/DK1991/000396 WO1992011378A1 (en) 1990-12-19 1991-12-18 A method of constructing synthetic leader sequences
KR1019930701890A KR930703450A (ko) 1990-12-19 1991-12-18 합성 선도 서열의 작제방법
SK62593A SK62593A3 (en) 1990-12-19 1991-12-18 Method of constructing synthetic leader sequences
ZA919932A ZA919932B (en) 1990-12-19 1991-12-18 A method of constructing synthetic leader sequences
CS931192A CZ119293A3 (en) 1990-12-19 1991-12-18 Method of constructing synthetic leading peptide sequence
CA002098731A CA2098731A1 (en) 1990-12-19 1991-12-18 Method of constructing synthetic leader sequences
MX9102684A MX9102684A (es) 1990-12-19 1991-12-19 Metodo para construir secuencias de peptido lider, sinteticas.
NO93932235A NO932235L (no) 1990-12-19 1993-06-17 Fremgangsmaate ved fremstilling av syntetiske ledersekvenser

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK300090A DK300090D0 (da) 1990-12-19 1990-12-19 Fremgangsmaade til fremstilling af leadersekvenser

Publications (1)

Publication Number Publication Date
DK300090D0 true DK300090D0 (da) 1990-12-19

Family

ID=8118017

Family Applications (1)

Application Number Title Priority Date Filing Date
DK300090A DK300090D0 (da) 1990-12-19 1990-12-19 Fremgangsmaade til fremstilling af leadersekvenser

Country Status (17)

Country Link
EP (1) EP0563175A1 (da)
JP (1) JPH06503957A (da)
KR (1) KR930703450A (da)
AU (1) AU660161B2 (da)
CA (1) CA2098731A1 (da)
CZ (1) CZ119293A3 (da)
DK (1) DK300090D0 (da)
FI (1) FI932831A0 (da)
HU (1) HUT68751A (da)
IE (1) IE914433A1 (da)
IL (1) IL100408A0 (da)
MX (1) MX9102684A (da)
NZ (1) NZ241011A (da)
PT (1) PT99848A (da)
SK (1) SK62593A3 (da)
WO (1) WO1992011378A1 (da)
ZA (1) ZA919932B (da)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI92601C (fi) * 1992-03-11 1994-12-12 Marja Makarow Menetelmä hyötyproteiinien erittämiseksi hiivoista
US5538863A (en) * 1993-07-01 1996-07-23 Immunex Corporation Expression system comprising mutant yeast strain and expression vector encoding synthetic signal peptide
US5639642A (en) * 1994-06-16 1997-06-17 Novo Nordisk A/S Synthetic leader peptide sequences
US6500645B1 (en) 1994-06-17 2002-12-31 Novo Nordisk A/S N-terminally extended proteins expressed in yeast
IL114160A (en) * 1994-06-17 2006-12-31 Novo Nordisk As Dna constructs encoding heterologous proteins and processes for the heterologous protein production in yeast
HRP940432B1 (en) * 1994-08-05 2003-10-31 Pliva Pharm & Chem Works Dna sequences encoding biosynthetic insulin precursors and process for preparation of insulin
CN1182451A (zh) 1995-03-17 1998-05-20 诺沃挪第克公司 新的内切葡聚糖酶
DK1975177T3 (da) 1996-03-01 2011-07-25 Novo Nordisk As Appetitundertrykkende peptid, formuleringer dermed og anvendelse deraf
WO1998026080A1 (en) 1996-12-13 1998-06-18 Chiron Corporation Method for expression of heterologous proteins in yeast
WO1999037793A1 (en) 1998-01-23 1999-07-29 Novo Nordisk A/S Process for making desired polypeptides in yeast
CA2392844A1 (en) 1999-12-29 2001-07-12 Novo Nordisk A/S Method for making insulin precursors and insulin precursor analogues having improved fermentation yield in yeast
AT410217B (de) * 2000-06-15 2003-03-25 Cistem Biotechnologies Gmbh Vektor und ein verfahren zur expression und selektion randomisierter peptid-sequenzen
IL157842A0 (en) 2001-03-22 2004-03-28 Novo Nordisk Healthcare Ag Coagulation factor vii derivatives
ATE532858T1 (de) 2001-09-27 2011-11-15 Novo Nordisk Healthcare Ag Menschliche gerinnungsfaktor-vii-polypeptide
EP2392655A3 (en) 2003-09-09 2012-02-29 Novo Nordisk Health Care AG Coagulation factor VII polypeptides
EP1687428A1 (en) 2003-11-14 2006-08-09 Novo Nordisk A/S Processes for making acylated insulin
JP5697831B2 (ja) 2003-12-03 2015-04-08 ノヴォ ノルディスク アー／エス 単鎖インシュリン
WO2005078116A1 (fr) * 2004-01-16 2005-08-25 Qiuyun Liu Methode permettant d'isoler de peptides antibacteriens et peptides isoles
MX2007012887A (es) 2005-04-18 2007-12-10 Novo Nordisk As Variantes il-21.
CN102660614A (zh) 2005-08-16 2012-09-12 诺沃-诺迪斯克有限公司 制备成熟胰岛素多肽的方法
WO2007031559A2 (en) 2005-09-14 2007-03-22 Novo Nordisk Health Care Ag Human coagulation factor vii polypeptides
JP5202338B2 (ja) 2006-02-27 2013-06-05 ノボ・ノルデイスク・エー／エス 新規インシュリン誘導体
US8518668B2 (en) 2006-09-27 2013-08-27 Novo Nordisk A/S Method for making maturated insulin polypeptides in a fungal cell
CN101778862B (zh) 2007-08-13 2014-12-17 诺沃-诺迪斯克有限公司 快速作用的胰岛素类似物
EP2178910B1 (en) 2007-08-15 2014-10-08 Novo Nordisk A/S Insulins with an acyl moiety comprising repeating units of alkylene glycol containing amino acids
ES2548304T3 (es) 2007-08-15 2015-10-15 Novo Nordisk A/S Análogos de la insulina que contienen una fracción acilo y alquilenglicol
WO2011089170A2 (en) 2010-01-22 2011-07-28 Novo Nordisk A/S Process for preparing fgf-21 with low degree of o-glycosylation
WO2010103038A1 (en) 2009-03-11 2010-09-16 Novo Nordisk A/S Interleukin-21 variants having antagonistic binding to the il-21 receptor
WO2011006982A2 (en) 2009-07-17 2011-01-20 Rigshospitalet Inhibitors of complement activation
EP2504355B1 (en) 2009-11-25 2015-07-22 Novo Nordisk A/S Method for making polypeptides
US9096843B2 (en) 2009-12-01 2015-08-04 Novo Nordisk A/S Peptidyl α-hydroxyglycine α-amidating lyases
US9815876B2 (en) 2010-03-05 2017-11-14 Omeros Corporation Chimeric inhibitor molecules of complement activation
US9074015B2 (en) * 2010-07-28 2015-07-07 Smartcells, Inc. Recombinantly expressed insulin polypeptides and uses thereof
JP6517018B2 (ja) 2012-02-09 2019-05-22 ヴァー２・ファーマシューティカルズ・アンパルトセルスカブＶＡＲ２ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ ＡｐＳ コンドロイチン硫酸グリカンのターゲティング
JP2015532307A (ja) 2012-10-15 2015-11-09 ノヴォ・ノルディスク・ヘルス・ケア・アーゲー 凝固因子ｖｉｉポリペプチド
US20160115216A1 (en) 2013-06-07 2016-04-28 Novo Nordisk A/S Method for Making Mature Insulin Polypeptides
CN106029688A (zh) * 2014-02-28 2016-10-12 诺和诺德股份有限公司 交配因子α原肽变体
US20210278406A1 (en) 2018-07-13 2021-09-09 Varct Diagnostic Aps Isolation of circulating cells of fetal origin using recombinant malaria protein var2csa

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK463887D0 (da) * 1987-09-07 1987-09-07 Novo Industri As Gaerleader
CA1340772C (en) * 1987-12-30 1999-09-28 Patricia Tekamp-Olson Expression and secretion of heterologous protiens in yeast employing truncated alpha-factor leader sequences
AU633020B2 (en) * 1988-07-23 1993-01-21 Novozymes Delta Limited New secretory leader sequences
DK105489D0 (da) * 1989-03-03 1989-03-03 Novo Nordisk As Polypeptid

Also Published As

Publication number Publication date
WO1992011378A1 (en) 1992-07-09
HU9301801D0 (en) 1993-10-28
SK62593A3 (en) 1993-10-06
FI932831L (fi) 1993-06-18
HUT68751A (en) 1995-07-28
NZ241011A (en) 1993-04-28
FI932831A7 (fi) 1993-06-18
IL100408A0 (en) 1992-09-06
KR930703450A (ko) 1993-11-30
PT99848A (pt) 1993-06-30
CZ119293A3 (en) 1994-02-16
EP0563175A1 (en) 1993-10-06
AU660161B2 (en) 1995-06-15
CA2098731A1 (en) 1992-06-19
IE914433A1 (en) 1992-07-01
JPH06503957A (ja) 1994-05-12
ZA919932B (en) 1992-08-26
FI932831A0 (fi) 1993-06-18
MX9102684A (es) 1992-06-01
AU9134891A (en) 1992-07-22

Similar Documents

Publication Publication Date Title
DK178889D0 (da) Fremgangsmaade til renovering af kloakroer
DK0454386T3 (da) Fremgangsmåde til fremstilling af saccharose-6-ester
FI932831A7 (fi) Menetelmä synteettisen johtosekvenssin valmistamiseksi
DK0453782T3 (da) Fremgangsmåde til fremstilling af kappa-casein-glycomacropeptid
DK161690D0 (da) Fremgangsmaade til fremstilling af enantiomere forbindelser
DK161788A (da) Fremgangsmaade til fremstilling af zidovudin
DK553582A (da) Fremgangsmaade til fremstilling af naphthoxyalkylaminer
DK603088A (da) Fremgangsmaade til fremstilling af multiglucosylforgrenede cyclodextriner
DK0465373T3 (da) Fremgangsmåde til fremstilling af kappa-carragenaner
DK177991A (da) Fremgangsmaade til fremstilling af peptider
DK361387D0 (da) Fremgangsmaade til fremstilling af piperidinopyrimidin
DK207990D0 (da) Fremgangsmaade til fremstilling af en ophoejet afbildning
DK162191D0 (da) Fremgangsmaade til fremstilling af prolinderivat
DK27988D0 (da) Fremgangsmaade til fremstilling af substituerede benzaldehyder
DK0572671T3 (da) Fremgangsmåder til fremstilling af kunstig kævle til dyrkning af shiitake
DK504988D0 (da) Fremgangsmaade til fremstilling af makrolidforbindelser
DK505888D0 (da) Fremgangsmaade til fremstilling af makrolidforbindelser
DK350288D0 (da) Fremgangsmaade til fremstilling af n-epoxypropyllactamer
DK215082A (da) Fremgangsmaade til fremstilling af 2-iminotiazolidinderivater
NO932235D0 (no) Fremgangsmaate ved fremstilling av syntetiske ledersekvenser
DK52390D0 (da) Redskab til tilberedning af omeletter
DK987D0 (da) Fremgangsmaade til fremstilling af tetrachlorpyri- din
DK98287A (da) Fremgangsmaade til fremstilling af imidazolylthiophenaldehyder
DK24190D0 (da) Fremgangsmaade til fremstilling af konservesdaaser af formstof
DK107892D0 (da) Fremgangsmaade til fremstilling af tensider

Legal Events

Date Code Title Description
ATS Application withdrawn